Affiliate and editorial disclosure: This physician-oriented analysis is editorially independent. We may earn a commission through the Official Site link. The arrangement does not affect the facts below, and it creates no assurance of eligibility, prescribing, delivery, refund approval, or weight change.
By DrBayer.com Editorial Team
Promise Evidence Grid
| Outcome gate | Less than 5% weight loss and enrollment goal not reached |
|---|---|
| Participation gate | Coaching, weight logs, daily check-ins, and provider forms |
| Account gate | Good standing |
| Deadline gate | Claim within 30 days after the 120-day period |
| Official Site | Confirm the current ShedRX terms |
The 120-day Shed Promise may stand out while you compare telehealth programs. This is not a broad satisfaction guarantee or a statement about the typical member’s result. It combines an outcome threshold, documented participation, account status, and a short claim window.
ShedRX also offers a convenient care package: online intake, licensed-provider review, access to coaching or tracking support, and home delivery if an independent prescriber approves medication. It presents compounded semaglutide and compounded tirzepatide as possible options rather than designed to support treatments. Readers comparing the category may also use this review of tirzepatide telehealth programs.
Gate 1: Two Outcome Tests Must Both Be Met
The promise applies when weight loss is less than 5% and the person has not reached the goal recorded at enrollment. Both parts matter. Reaching the personal enrollment goal could prevent qualification even if the percentage loss remains below 5%. Similarly, missing the goal does not qualify someone whose loss reaches the stated percentage threshold.
That rule does not tell prospective members what usually happens. Body response varies, and a conditional commercial policy cannot establish effectiveness for an individual. Save the starting weight and enrollment goal so the comparison is based on the same figures later.
Gate 2: Four Types of Participation
Eligibility also depends on completing four coaching appointments, recording eight weight logs, and making at least 60 of 120 daily check-ins. In addition, provider follow-up forms must be submitted on time. These are separate tasks; doing extra check-ins does not erase a missed coaching requirement.
Coaching and tracking can be genuinely useful. They create structure, help identify barriers, and give the care team more information. But when they are also conditions of a promise, the member should know how attendance and entries are recorded. Ask whether canceled appointments can be rescheduled and how to correct a missing log.
Gate 3: Account Status and Claim Timing
The account must remain in good standing. A claim must then be submitted within 30 days after the 120-day period. Waiting beyond that window can defeat an otherwise complete record.
A simple evidence folder can include enrollment goal, dated coaching confirmations, eight weights, the check-in count, sent provider forms, payment history, and the final claim. The purpose is not to predict approval. It is to understand what the stated conditions require.
The Promise Is Separate From Ordinary Refund Rules
Shed’s recurring terms describe monthly or 28-day billing with a minimum of two full months. Cancellation must occur at least 72 hours before the next billing or shipment cutoff. Monthly fees already charged are generally non-refundable, while prescription medication that has shipped cannot be returned or restocked.
Multi-month refunds use another calculation. Only qualifying cycles that remain unfulfilled may qualify, and used months can be repriced at the standard monthly rate. Lack of results, change of mind, and nonparticipation are not qualifying reasons. These financial rules continue to matter regardless of how a reader understands the 120-day promise.
A Price Grid With Three Contexts
As of July 25, 2026, the public figures varied by page. The GLP-1 offer showed compounded semaglutide as low as $159 per month and compounded tirzepatide from $239 per month. The weight-loss catalog showed $249 and $349 starting prices. The legal terms named $199 and $299 as standard renewal rates after the minimum term.
Differences may involve plan, minimum term, promotion, or inclusions. Verify the exact checkout charge and renewal schedule. Ask whether medication, supplies, delivery, provider access, coaching, and tracking are included and whether price changes with the prescribed option or dose.
Clinical Roles Behind the Program
Shed Holdings manages the platform and service program. The affiliated Provider Group is involved in access to clinicians. The individual licensed prescriber decides independently whether treatment is appropriate; a prescription is never guaranteed. If approved, a separate dispensing pharmacy fills and ships the prescription. Shed is not the dispensing pharmacy.
This separation matters if something goes wrong. Account and billing questions go to the program. Diagnosis, dose, and side-effect questions require the clinical team. Product labeling, storage, and fulfillment questions may involve the dispensing pharmacy.
Compounding and GLP-1 Safety
Compounded medication is not FDA approved. FDA has not evaluated the compounded preparation for safety, effectiveness, or quality. It should not be assumed equivalent to an FDA-approved brand. Outcomes from Wegovy, Zepbound, or other branded-drug trials cannot be transferred to Shed’s compounded preparations or treated as evidence of a member’s likely result. See this explanation of FDA concerns about unapproved GLP-1 drugs for additional context.
The prescriber needs a complete medical and medication history. Discuss pregnancy or breastfeeding, pancreatitis, gallbladder or kidney disease, severe gastrointestinal conditions, diabetic retinopathy, allergies, and planned anesthesia. Report all prescriptions, over-the-counter products, and supplements. Personal or family medullary thyroid carcinoma (MTC), or Multiple Endocrine Neoplasia syndrome type 2 (MEN2), is a serious warning that must be disclosed.
Online care is not an emergency service. Call 911 or obtain local emergency care for severe, sudden, or rapidly worsening symptoms. Persistent vomiting, severe abdominal pain, dehydration, breathing difficulty, or a serious allergic response needs prompt medical attention rather than waiting for a routine check-in.
Promise-Focused Buyer Fit
Potential fit: An adult who values remote licensed review, can participate in structured support, accepts recurring billing, and prefers pharmacy delivery after approval. The choice of compounded semaglutide or tirzepatide may be helpful when the clinician finds one appropriate.
Not a fit: Someone seeking certain approval, guaranteed loss, an unconditional refund, a one-month commitment, or brand-level evidence for a compounded preparation. It is also a poor match for anyone unwilling to complete forms, coaching, logs, and check-ins or unable to resolve a medical contraindication.
Questions That Test the Promise Before Purchase
- Where is my enrollment goal stored, and how is the 5% calculation performed?
- What proves completion of each coaching visit, weight log, and daily check-in?
- When are provider forms due, and what defines good standing?
- What is the exact start and end date of my 120-day period?
- How is a claim submitted during the following 30 days?
- Which billing, cancellation, and multi-month refund rules remain separate?
Our Assessment
The strongest interpretation of the Shed Promise is as an adherence-backed protection with multiple gates. It complements, but does not replace, the program’s core services or ordinary terms. Judge ShedRX first on clinical access, support, pharmacy transparency, total cost, and medication safety. Then decide whether the conditional promise adds meaningful value for the way you will actually participate.
Broader lifestyle measures may still support a medical plan; this discussion of weight-management support beyond GLP-1 treatment can help frame questions, but supplements should also be disclosed to the prescriber.
Medical disclaimer: This content is for general education and is not medical advice, diagnosis, or treatment. Prescription decisions require an individualized assessment by a licensed clinician familiar with your health history.